**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 131-11-3 |Dimethyl phthalate | > 99.5 | 205-011-6 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XI
Risk Phrases: 36/37
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Irritating to eyes and respiratory system.
Potential Health Effects
Eye:
Produces irritation, characterized by a burning sensation, redness,
tearing, inflammation, and possible corneal injury. May cause
transient corneal injury.
Skin:
Prolonged and/or repeated contact may cause irritation and/or
dermatitis. Dimethyl phthalate has low acute toxicity in
experimental animals exposed by the oral, inhalation and dermal
routes. In other words, it is not acutely toxic. However, repeated
and/or prolonged skin contact may result in the absorption of
harmful amounts. Dimethyl phthalate was not a sensitizer in guinea
pigs and has not been reported to be a sensitizer from its use during
WWII as an insect repellent; however, it has been called an allergen
in one Russian study of human patch testing.
Ingestion:
Causes gastrointestinal irritation with nausea, vomiting and
diarrhea. May cause central nervous system depression.
Inhalation:
Inhalation of high concentrations may cause central nervous system
effects characterized by nausea, headache, dizziness, unconsciousness
and coma. May cause respiratory tract irritation. Exposure to
dimethyl phthalate occurs from spray or mist, rather than from the
vapor, unless heat is applied. Intermittent exposure produced blood,
liver and kidney changes in rats.
Chronic:
Some adverse reproductive effects were seen in animal studies. Few
defects occurred when rats were given injections of dimethyl
phthalate intraperitoneally on gestational days 5, 10 and 15.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
In case of contact, immediately flush eyes with plenty of water for
at least 15 minutes. Get medical aid.
Skin:
In case of contact, flush skin with plenty of water. Remove
contaminated clothing and shoes. Get medical aid if irritation
develops and persists. Wash clothing before reuse.
Ingestion:
If swallowed, do not induce vomiting unless directed to do so by
medical personnel. Never give anything by mouth to an unconscious
person. Get medical aid.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial
respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear.
Extinguishing Media:
In case of fire, use water, dry chemical, chemical foam, or
alcohol-resistant foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation. Avoid
contact with eyes, skin, and clothing. Avoid breathing spray or mist.
Storage:
Keep from contact with oxidizing materials. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local exhaust ventilation to keep airborne concentrations below the
permissible exposure limits.
Exposure Limits
CAS# 131-11-3:
United Kingdom, OES - TWA: 5 mg/m3 TWA
United Kingdom, OES - STEL: 10 mg/m3 STEL
United States OSHA: 5 mg/m3 TWA
Belgium - TWA: 5 mg/m3 VLE
France - VME: 5 mg/m3 VME
Malaysia: 5 mg/m3 TWA
Russia: 0.3 mg/m3 TWA
Spain: 5 mg/m3 VLA-ED
Personal Protective Equipment
Eyes:
Wear chemical splash goggles.
Skin:
Wear appropriate gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to minimize
contact with skin.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Always use
a NIOSH or European Standard EN 149 approved
respirator when necessary.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: colorless to light yellow
Odor: ester-like - weak odor
pH: Not available.
Vapor Pressure: .0015 mm Hg @ deg 20
Viscosity: 17.2 cP 25 deg C
Boiling Point: 282 deg C
Freezing/Melting Point: 2 deg C
Autoignition Temperature: 460 deg C ( 860.00 deg F)
Flash Point: 295 deg F ( 146.11 deg C)
Explosion Limits, lower: 0.9
Explosion Limits, upper: 8.0%
Decomposition Temperature: Not available.
Solubility in water: 0.4% (20 C) in water.
Specific Gravity/Density: 1.19
Molecular Formula: C10H10O4
Molecular Weight: 194.19
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable.
Conditions to Avoid:
No specific conditions to avoid noted.
Incompatibilities with Other Materials:
Oxidizing agents, acids, bases, and nitrates.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 131-11-3: TI1575000
LD50/LC50:
CAS# 131-11-3: Dermal, guinea pig: LD50 = >10 mL/kg; Draize test,
rabbit, eye: 119 mg; Oral, mouse: LD50 = 6800 mg/kg; Oral, rabbit:
LD50 = 4400 uL/kg; Oral, rat: LD50 = 6800 mg/kg; Skin, rabbit: LD50 =
>20 mL/kg; Skin, rat: LD50 = >4800 mg/kg.
Carcinogenicity:
Dimethyl phthalate -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
USA RQ: CAS# 131-11-3: 5000 lb final RQ; 2270 kg final RQ
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37 Irritating to eyes and respiratory system.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 39 Wear eye/face protection.
WGK (Water Danger/Protection)
CAS# 131-11-3: 1
Canada
CAS# 131-11-3 is listed on Canada's DSL List.
CAS# 131-11-3 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 131-11-3 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #3 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
2,3-Butanedione monoxime, 96% (uv-vis)
| 57-71-6 |
|
Dimethylglyoxime, reagent ACS
| 95-45-4 |
|
Methyl 3,5-Dibenzyloxybenzoate, 98%
| 58605-10-0 |
|
Diethylamine, 99+%
| 109-89-7 |
|
Bis(2-hydroxyethyl)ether, 99%
| 111-46-6 |
|
2-Methoxyethyl ether, 99%
| 111-96-6 |
|
2-(2-Butoxyethoxy)-ethanol 99+%
| 112-34-5 |
|
2-(2-Ethoxyethoxy)-Ethanol, 98+%
| 111-90-0 |
|
Diethylenetriamine, 98+%
| 111-40-0 |
|
Diisopropylamine, 99+%
| 108-18-9 |
|
Tris(3,3,4,4,5,5,6,6,7,7,8,8-tridecafluorooctyl)phenyltin
| 175354-30-0 |
|
N,N-Dimethylacetamide, 99+% spectrophotometric grade
| 127-19-5 |
|
Dimethyl phthalate, p.a.
| 131-11-3 |
|
2-Hydroxyethyl acrylate, stabilized, 97%
| 818-61-1 |
|
4-Fluorophenylboronic Acid
| 1765-93-1 |
|
1-(3-Dimethylaminopropyl)-3-Ethylcarbodiimide Methiodide, 98%
| 22572-40-3 |
|
2-Chlorophenothiazine, 99%
| 92-39-7 |
|
Ethyl Butyrylacetate, 98%
| 3249-68-1 |
|
3-Methoxypropylisothiocyanate
| 17702-11-3 |
|
2,6-Dibenzylidenecyclohexanone
| 897-78-9 |
|
(1R,2R)-2-Amino-1-(4-Nitrophenyl)Propane-1,3-Diol, 96%
| 716-61-0 |
|
Docosanoic Acid, Tech. 85%
| 112-85-6 |
|
Silica gel, for column chromatography, 0.035-0.070 mm, pore diameter
| 7631-86-9 |
|
Phenylazoformic acid 2-phenylhydrazide, suitable for colorimetric
| 538-62-5 |
|
sym-Diphenylcarbazide, 99+%
| 140-22-7 |
|
Diphenylamine-4-sulfonic acid sodium salt, reagent acs
| 6152-67-6 |
|
Cis-2, trans-4-hexadiene
| 5194-50-3 |
|
Diphenylthiocarbazone, reagent ACS, 85+% (UV-VIS)
| 60-10-6 |
|
2,6-Diisopropylphenol, 99%
| 2078-54-8 |
|
3-Heptanone, 98%
| 106-35-4 |
|
2,2'-Dipyridyl, 99+%
| 366-18-7 |
|
Dodecane, Spectro Grade, 98% (GC)
| 112-40-3 |
|
Diethyl Acetamidomalonate, 99+%
| 1068-90-2 |
|
Brij 35
| 7732-18-5 |
|
1-(Pyrrolidino)-1-cyclohexene
| 1125-99-1 |
|
(4S)-(+)-4-Benzyl-3-Propionyl-2-Oxazolidinone, 97%
| 101711-78-8 |
|
N-[(1S)-2-Hydroxy-1-Phenethyl)]Ethoxycarboxamide
| 0-01-1 |
|
Dodecyl Sulfate, Sodium Salt, 99%
| 151-21-3 |
|
Eosin B (Cert)
| 548-24-3 |
|
Ethanolamine, scintillation grade (CO2 absorber)
| 141-43-5 |
|
(R)-(+)-2-(tert-Butoxycarbonylamino)-3-phenyl-1-propanol, 98%
| 106454-69-7 |
|
(R)-1-(2-Hydroxy-1-Phenylethyl)-1,5-Dihydropyrrol-2-One
| 158271-95-5 |
|
Chelerythrine chloride
| 3895-92-9 |
|
Cyclopiazonic Acid
| 18172-33-3 |
|
D609 Potassium Salt
| 83373-60-8 |
|
Daidzein, 98%
| 486-66-8 |
|
Fumonisin B1, 98%
| 116355-83-0 |
|
Sodium Tert. Butoxide
| 865-48-5 |
|
1-(4-Hydroxyphenyl)piperazine dihydrobromide
| 38869-37-3 |
|
1,2-Benzenedithiol, 96%
| 17534-15-5 |
|
|